FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/07/034641 [Registered on: 06/07/2021] Trial Registered Prospectively
Last Modified On: 03/07/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   Ayurveda treatment for ADHD in children 
Scientific Title of Study   Clinical study to evaluate the effectiveness of Kushmanda ghrita along with Abhyanga and Shirodhara in Attention Deficit Hyperactivity Disorder in children 
Trial Acronym  AY-ADHD 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Binisha C 
Designation  Post graduate scholar 
Affiliation  Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital 
Address  Room No. 16, Department of Kaumarabhritya
Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital, Hassan – 573201, Karnataka, India
Hassan
KARNATAKA
573201
India 
Phone  8281020492  
Fax    
Email  binishachothayoth@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Shailaja Uppinakuduru 
Designation  Professor and Head 
Affiliation  Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital 
Address  Room No. 16, Department of Kaumarabhritya
Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital, Hassan – 573201, Karnataka, India
Hassan
KARNATAKA
Dr Shailaja U
India 
Phone  9448816433  
Fax    
Email  rao.shaila@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Binisha C 
Designation  Post graduate scholar 
Affiliation  Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital 
Address  Room No. 16, Department of Kaumarabhritya
Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital, Hassan – 573201, Karnataka, India
Hassan
KARNATAKA
573201
India 
Phone  8281020492  
Fax    
Email  binishachothayoth@gmail.com  
 
Source of Monetary or Material Support  
Sri Dharmasthala Manjuntheshwara College of Ayurveda and Hospital, Hassan, Karnataka, India 
 
Primary Sponsor  
Name  Sri Dharmasthala Manjuntheshwara College of Ayurveda and Hospital Hassan Karnataka India 
Address  Room No. 16, Department of Kaumarabhritya,Sri Dharmasthala Manjuntheshwara College of Ayurveda and Hospital, Hassan, Karnataka, India 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Binisha C  SDM College of Ayurveda and Hospital  Room No. 16, Department of Kaumarabhritya, Sri Dharmasthala Manjuntheshwara College of Ayurveda and Hospital, Hassan, Karnataka, India
Hassan
KARNATAKA 
8281020492

binishachothayoth@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
SDM College of Ayurveda and Hospital, Hassan  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:F902||Attention-deficit hyperactivity disorder, combined type. Ayurveda Condition: UNMADAH,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  1. Abhyanga and Shirodhara with Murchitha tila taila 2. Kushmanda ghrita internally  Kushmanda ghrita - 5 ml twice daily (below 7 years) for 30 days Kushmanda ghrita - 10 ml twice daily (above 7 years) for 30 days 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  3.00 Year(s)
Age To  12.00 Year(s)
Gender  Both 
Details  • Children of the age group of 3-12 years irrespective of gender, religion, and socioeconomic status.
• The children whose parents are willing to participate in the study and ready to sign the consent form.
 
 
ExclusionCriteria 
Details  • Children with other CNS manifestations like Cerebral palsy with hyperkinetic disorder, history of brain damage and other syndromes affecting CNS.
• Children with impaired vision/ impaired hearing.
• Speech delay due to any other secondary causes.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Reduction in Attention deficit, hyperactivity and impulsivity  45 days 
 
Secondary Outcome  
Outcome  TimePoints 
Patient well being  45 days 
 
Target Sample Size   Total Sample Size="20"
Sample Size from India="20" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   15/07/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Researchers who provide a methodologically sound proposal.

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response (Others) -  Data will be made available on request.

  6. For how long will this data be available start date provided 23-01-2023 and end date provided 23-01-2024?
    Response (Others) -  One year post publication

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary   The objective of the study is to evaluate the effect of Abhyanga, nadi sweda, shirodhara and Kushmanda ghrita in the management of ADHD in children. 20 subjects with ADHD will be administered with abhyanga, nadi sweda and shirodhara externally and Kushmanda ghrita internally. After the study period of 45 days, the subjects will be assessed for reduction in attention deficit, hyperactivity and impulsivity. 
Close